Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). (2021)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.08.20227876
PubMed Identifier: 33215168
Publication URI: http://europepmc.org/abstract/MED/33215168
Type: Journal Article/Review
Parent Publication: medRxiv : the preprint server for health sciences